Solventum Corp reported $14.24B in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
Align Technology USD 6.93M 9.11M Mar/2026
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Cencora USD 154.34M 78.21B Mar/2026
Dexcom USD 3.1M 1.1M Mar/2026
Insulet USD 11M 3.7M Jun/2026
Solventum Corp USD 14.24B 146M Jun/2026
West Pharmaceutical Services USD 1.9M 1.7M Mar/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026